Published in Crit Care on September 07, 2000
Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation. Respir Res (2007) 1.29
Mechanisms of bacterial pathogenicity. Postgrad Med J (2002) 1.29
Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study. Crit Care (2006) 1.12
Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS One (2010) 1.07
Pulmonary contusion primes systemic innate immunity responses. J Trauma (2009) 0.93
Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B. Infect Immun (2002) 0.87
Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers. Crit Care Res Pract (2012) 0.85
HLA-DR expression, cytokines and bioactive lipids in sepsis. Arch Med Sci (2014) 0.84
Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept. Clin Exp Immunol (2008) 0.83
Insulin and the critically ill. Crit Care (2002) 0.82
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis. Crit Care (2012) 0.81
Ozone therapy in induced endotoxemic shock. II. The effect of ozone therapy upon selected histochemical reactions in organs of rats in endotoxemic shock. Inflammation (2007) 0.79
Anti-inflammatory effects of Siegesbeckia orientalis ethanol extract in in vitro and in vivo models. Biomed Res Int (2014) 0.77
Two Kdo-heptose regions identified in Hafnia alvei 32 lipopolysaccharide: the complete core structure and serological screening of different Hafnia O serotypes. J Bacteriol (2008) 0.77
Neutrophil 'connectivity': key to neutrophil-mediated tissue injury? Crit Care (2003) 0.76
Oxidative and pre-inflammatory stress in wedge resection of pulmonary parenchyma using the radiofrequency ablation technique in a swine model. J Cardiothorac Surg (2012) 0.75
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
Pathogenetic mechanisms of septic shock. N Engl J Med (1993) 6.64
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (1998) 6.49
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet (1993) 6.39
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med (1994) 5.55
MIF as a glucocorticoid-induced modulator of cytokine production. Nature (1995) 5.21
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med (1998) 4.17
Septic shock: pathogenesis. Lancet (1991) 3.99
Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med (2000) 3.89
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res (1991) 3.49
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med (1997) 2.98
Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem (1999) 2.60
Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science (1991) 2.37
Structure and dimerization of a soluble form of B7-1. Immunity (2000) 2.33
Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1989) 2.24
Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg (1990) 2.05
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
The toll of innate immunity on microbial pathogens. N Engl J Med (1999) 1.98
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86
Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med (1999) 1.53
Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci U S A (1998) 1.51
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol (1997) 1.37
Fly development genes lead to immune find. Science (1998) 1.12
Biological variation in the development of sepsis after surgery or trauma. Lancet (1993) 1.04
Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids (1994) 0.95
Endotoxin-induced acute lung injury in rats. Role of insulin. Pulm Pharmacol Ther (1999) 0.94
Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response. Arch Surg (1993) 0.92
Enhanced survival to endotoxin in guinea pigs fed IV fish oil emulsion. Lipids (1988) 0.91
Reversal of the toxic effects of cachectin by concurrent insulin administration. Am J Physiol (1989) 0.89
Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation (1998) 0.87
Metabolism of dietary alpha-linolenic acid vs. eicosapentaenoic acid in rat immune cell phospholipids during endotoxemia. Lipids (1998) 0.87
Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: a hypothesis. Diabetologia (2000) 0.85
Free radical generation, lipid peroxidation and essential fatty acids in patients with septicemia. Prostaglandins Leukot Essent Fatty Acids (1991) 0.85
Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaBalpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J Biol Chem (1997) 0.84
A role for the endocrine and pro-inflammatory mediator MIF in the control of insulin secretion during stress. Diabetes Metab Res Rev (2000) 0.82
MIF, a previously unrecognized pituitary hormone and macrophage cytokine, is a pivotal mediator in endotoxic shock. Circ Shock (1994) 0.79
Suppression of human T-cell growth in vitro by cis-unsaturated fatty acids: relationship to free radicals and lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids (1994) 0.78
Septic shock: finding the way through the maze. Lancet (1999) 0.77
Effects of a fish oil diet on pigs' cardiopulmonary response to bacteremia. JPEN J Parenter Enteral Nutr (1991) 0.77
Effects of continuous tube feeding of dietary fat emulsions on eicosanoid production and on fatty acid composition during an acute septic shock in rats. Biochim Biophys Acta (1994) 0.77
Free radicals: biology and relevance to disease. J Assoc Physicians India (1990) 0.77
Tumour necrosis factor/cachectin: biology and relevance to disease. J Assoc Physicians India (1991) 0.77
Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory. Nutrition (2003) 1.63
Nutritional factors in the pathobiology of human essential hypertension. Nutrition (2001) 0.89
Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition (2002) 0.86
Can perinatal supplementation of long-chain polyunsaturated fatty acids prevent diabetes mellitus? Eur J Clin Nutr (2003) 0.81
Essential fatty acids as possible enhancers of the beneficial actions of probiotics. Nutrition (2002) 0.78